Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - CASH & EQUIVALENTS
Cash & Equivalents PCVX - Vaxcyte, Inc.
397 M
LAST VALUE
140.03%
2 YEAR CAGR
43.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR